RxDoctor Payments Data

Megan Saia, PA

Physician Assistant · Manahawkin, NJNPI 1548541063

Payments from drug & device makers

$985in general payments, 2019–2025

Across 57 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$461
  • Janssen Scientific Affairs, LLC$182
  • Takeda Pharmaceuticals U.S.A., Inc.$99
  • Bristol Myers Squibb$65
  • GSK$56
  • Aimmune Therapeutics, Inc.$33
  • plus $90 from 5 others

What the payments were for

  • Food & beverage$985100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$985 in reported general payments places this provider in the 75th percentile of 2,726 physician assistant providers in New Jersey.

See all physician assistant providers in New Jersey

Medicare billing

Part B allowed, 2024
$58,954
Medicare patients
303
Services billed
461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide25$22,187
Dexlansoprazole DrDexlansoprazole39$10,153
DexilantDexlansoprazole23$6,709
Pantoprazole Sodium327$4,855
Omeprazole147$2,301
Famotidine105$1,912
Esomeprazole Magnesium57$1,863
Lubiprostone12$1,791
Sucralfate12$1,493
Mesalamine12$930
Ondansetron OdtOndansetron22$322
Dicyclomine Hcl11$168
Lactulose13$139
Ciprofloxacin Hcl14$124
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$124

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$461$22,18725 claims
Takeda Pharmaceuticals U.S.A., Inc.Dexilant$99$6,70923 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,726 physician assistant providers in New Jersey.

Other physician assistant in Manahawkin

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →